Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms

Approximately 30% of Major Depressive Disorder (MDD) patients develop treatment-resistant depression (TRD). Among the different causes that make TRD so challenging in both clinical and research contexts, major roles are played by the inadequate understanding of MDD pathophysiology and the limitation...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcatili, Matteo, Sala, Carlo, Dakanalis, Antonios, Colmegna, Fabrizia, D’Agostino, Armando, Gambini, Orsola, Dell’Osso, Bernardo, Benatti, Beatrice, Conti, Luciano, Clerici, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Novel Strategies for the Treatment of Depression
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649879/
https://www.ncbi.nlm.nih.gov/pubmed/33224469
http://dx.doi.org/10.1177/2045125320968331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649879/
https://www.ncbi.nlm.nih.gov/pubmed/33224469
http://dx.doi.org/10.1177/2045125320968331

Ejemplares similares